Hany Hammad
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
International consensus on adolescent metabolic health: prevention of obesity and type 2 diabetes.
Journal: Diabetology & metabolic syndrome
Published: December 19, 2025
Sound therapy in renal disease management: a narrative review by the Kasr Al-Ainy Nephrology Group (KANG).
Journal: International urology and nephrology
Published: October 19, 2025
Dual-faced guardians: SGLT2 inhibitors' kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG).
Journal: Diabetology & metabolic syndrome
Published: February 04, 2025
The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease.
Journal: The American journal of the medical sciences
Published: August 06, 2024
Evaluation of Serum Visfatin as a Biomarker of Lupus Nephritis in Egyptian Patients with Systemic Lupus Erythematosus.
Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Published: July 12, 2024
Brain-derived Neurotrophic Factor Level and Gene Polymorphism as Risk Factors for Depression in Patients with type 2 Diabetes Mellitus- A Case-Controlled Study.
Journal: Current diabetes reviews
Published: September 07, 2023
Response to the Letter to the Editor: Are SGLT-2 inhibitors "the elephant in the room" of non-diabetic glomerulonephritis? Considerations about the background immunosuppressive treatment.
Journal: International urology and nephrology
Published: April 23, 2023
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Journal: Renal failure
Published: March 28, 2023
Risk Stratification in People with Diabetes for Fasting During Ramadan: Consensus from Arabic Association for the Study of Diabetes and Metabolism.
Journal: Current diabetes reviews
Published: February 19, 2023
Effect of sodium-glucose transporter 2 inhibitor empagliflozin on proteinuria and kidney function progression in patients with non-diabetic glomerulonephritis: a pilot superiority randomized controlled trial.
Journal: International urology and nephrology
Published: June 12, 2022
Last Updated: 09/26/2026